Local IFNα enhances the anti-tumoral efficacy of systemic anti-PD1 to prevent tumor relapse

BACKGROUND: Tumor relapse constitutes a major challenge for anti-tumoral treatments, including immunotherapies. Indeed, most cancer-related deaths occur during the tumor relapse phase. METHODS: We designed a mouse model of tumor relapse in which mice transplanted with E7(+) TC1 tumor cells received...

Descripción completa

Detalles Bibliográficos
Autores principales: Guerin, Marion v, Regnier, Fabienne, Thoreau, Maxime, Vimeux, Lene, Benard, Matthieu, Dransart, Estelle, Penny, Hweixian L, Johannes, Ludger, Trautmann, Alain, Bercovici, Nadege
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Basic Tumor Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689071/
https://www.ncbi.nlm.nih.gov/pubmed/33239415
http://dx.doi.org/10.1136/jitc-2020-000996

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689071/
https://www.ncbi.nlm.nih.gov/pubmed/33239415
http://dx.doi.org/10.1136/jitc-2020-000996

Ejemplares similares